Invasive Fungal Infections Recruiting Phase 2 Trials for Posaconazole (DB01263)

Back to Invasive Fungal Infections

Also known as: Invasive Fungal Infection / Invasive Mycosis / Invasive Infection, Fungal / Infection, Invasive Fungal / Invasive Fungal Disease / Fungal Invasive Disease / Invasive fungal infection (disorder) / Systemic fungal infection NOS / Disseminated mycosis / Systemic mycosis / Systemic mycosis (disorder)

Indication	Status	Phase
DBCOND0030131 (Invasive Fungal Infections)	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04665037	Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)	Treatment	Posaconazole (DB01263)